190 related articles for article (PubMed ID: 21225866)
1. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
2. CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells.
Desai A; Webb B; Gerson SL
Radiother Oncol; 2014 Mar; 110(3):538-45. PubMed ID: 24440048
[TBL] [Abstract][Full Text] [Related]
3. Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in CD133
Fang LZ; Zhang JQ; Liu L; Fu WP; Shu JK; Feng JG; Liang X
Oncol Res; 2017 May; 25(5):819-829. PubMed ID: 27983936
[TBL] [Abstract][Full Text] [Related]
4. Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells.
Yang M; Yan M; Zhang R; Li J; Luo Z
Cancer Sci; 2011 Oct; 102(10):1774-81. PubMed ID: 21740477
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.
Won C; Kim BH; Yi EH; Choi KJ; Kim EK; Jeong JM; Lee JH; Jang JJ; Yoon JH; Jeong WI; Park IC; Kim TW; Bae SS; Factor VM; Ma S; Thorgeirsson SS; Lee YH; Ye SK
Hepatology; 2015 Oct; 62(4):1160-73. PubMed ID: 26154152
[TBL] [Abstract][Full Text] [Related]
6. Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling.
Peng H; Ye T; Deng L; Yang X; Li Q; Tong J; Guo J
Gut Liver; 2024 May; 18(3):476-488. PubMed ID: 37458065
[TBL] [Abstract][Full Text] [Related]
7. Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.
Meng X; Li M; Wang X; Wang Y; Ma D
Cancer Sci; 2009 Jun; 100(6):1040-6. PubMed ID: 19385971
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer.
Lewis KM; Bharadwaj U; Eckols TK; Kolosov M; Kasembeli MM; Fridley C; Siller R; Tweardy DJ
Lung Cancer; 2015 Nov; 90(2):182-90. PubMed ID: 26410177
[TBL] [Abstract][Full Text] [Related]
9. [The utilization and limitation of CD133 epitopes in lung cancer stem cells research].
Chen Y; Zhong H
Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):825-9. PubMed ID: 22008114
[TBL] [Abstract][Full Text] [Related]
10. PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth.
Abe Y; Sano T; Otsuka N; Ogawa M; Tanaka N
Commun Biol; 2024 May; 7(1):593. PubMed ID: 38760429
[TBL] [Abstract][Full Text] [Related]
11. The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells.
Wan X; Ma D; Song G; Tang L; Jiang X; Tian Y; Yi Z; Jiang C; Jin Y; Hu A; Bai Y
J Bioenerg Biomembr; 2024 Jun; 56(3):323-332. PubMed ID: 38441855
[TBL] [Abstract][Full Text] [Related]
12. LILRB2 inhibition enhances radiation sensitivity in non-small cell lung cancer by attenuating radiation-induced senescence.
Chen X; Yuan M; Zhong T; Wang M; Wu F; Lu J; Sun D; Xiao C; Sun Y; Hu Y; Wu M; Wang L; Yu J; Chen D
Cancer Lett; 2024 Jul; 593():216930. PubMed ID: 38705566
[TBL] [Abstract][Full Text] [Related]
13. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling.
Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
[TBL] [Abstract][Full Text] [Related]
14. IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.
Guo J; Kim D; Gao J; Kurtyka C; Chen H; Yu C; Wu D; Mittal A; Beg AA; Chellappan SP; Haura EB; Cheng JQ
Oncogene; 2013 Jan; 32(2):151-9. PubMed ID: 22330135
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation.
Sun J; Yu M; Lu Y; Thakur C; Chen B; Qiu P; Zhao H; Chen F
Cancer Lett; 2014 May; 346(2):257-63. PubMed ID: 24434654
[TBL] [Abstract][Full Text] [Related]
16. ATR Inhibitor M6620 (VX-970) Enhances the Effect of Radiation in Non-Small Cell Lung Cancer Brain Metastasis Patient-Derived Xenografts.
Baschnagel AM; Elnaggar JH; VanBeek HJ; Kromke AC; Skiba JH; Kaushik S; Abel L; Clark PA; Longhurst CA; Nickel KP; Leal TA; Zhao SG; Kimple RJ
Mol Cancer Ther; 2021 Nov; 20(11):2129-2139. PubMed ID: 34413128
[TBL] [Abstract][Full Text] [Related]
17. Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity.
Moriwaki K; Okudo K; Haraguchi N; Takeishi S; Sawaki H; Narimatsu H; Tanemura M; Ishii H; Mori M; Miyoshi E
Cancer Sci; 2011 Jun; 102(6):1164-70. PubMed ID: 21392166
[TBL] [Abstract][Full Text] [Related]
18. A coumarin-furoxan hybrid as novel nitric oxide donor induced cell apoptosis and ferroptosis in NSCLC by promoting S-nitrosylation of STAT3 and negative regulation of JAK2-STAT3 pathway.
Cao F; Li M; Wang W; Yi Y; Chen Y; Liu H
Biochem Pharmacol; 2024 Apr; 222():116068. PubMed ID: 38387529
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of cancer stem cells in ovarian yolk sac tumors.
Suzuki S; Terauchi M; Umezu T; Kajiyama H; Shibata K; Nawa A; Kikkawa F
Cancer Sci; 2010 Oct; 101(10):2179-85. PubMed ID: 20804503
[TBL] [Abstract][Full Text] [Related]
20. CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation.
Fukamachi H; Shimada S; Ito K; Ito Y; Yuasa Y
Cancer Sci; 2011 Jul; 102(7):1313-21. PubMed ID: 21457403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
